Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lang

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 6, 2015
RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxietyChrista Hohoff, Heike Weber, Jan Richter, et al.
Lancet Regional Health. Americas|October 25, 2023
Trends and disparities in deep brain stimulation utilization in the United States: a Nationwide Inpatient Sample analysis from 1993 to 2017Can Sarica, Christopher R Conner, Kazuaki Yamamoto, et al.
Journal of Neurology|March 22, 2022
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemicStefanie Völk, Markus Pfirrmann, Uwe Koedel, et al.
Journal of Hepatology|March 2, 2010
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirinStefan Wirth, Carmen Ribes-Koninckx, Maria Angeles Calzado, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2021
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysisMiriam A Schiele, Andreas Reif, Jiaxi Lin, et al.
Translational Psychiatry|February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypesMichael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
Molecular Psychiatry|August 10, 2022
Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traitsAet O'Leary, Noèlia Fernàndez-Castillo, Gabriela Gan, et al.
Annals of Hematology|January 25, 2023
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group studyDietger Niederwieser, Thomas Lang, Rainer Krahl, et al.
Translational Psychiatry|May 25, 2019
A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disordersChristopher Rayner, Jonathan R I Coleman, Kirstin L Purves, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2016
Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2Carrie M Nielson, Ching-Ti Liu, Albert V Smith, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 6, 2015
RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxietyChrista Hohoff, Heike Weber, Jan Richter, et al.
Lancet Regional Health. Americas|October 25, 2023
Trends and disparities in deep brain stimulation utilization in the United States: a Nationwide Inpatient Sample analysis from 1993 to 2017Can Sarica, Christopher R Conner, Kazuaki Yamamoto, et al.
Journal of Neurology|March 22, 2022
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemicStefanie Völk, Markus Pfirrmann, Uwe Koedel, et al.
Journal of Hepatology|March 2, 2010
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirinStefan Wirth, Carmen Ribes-Koninckx, Maria Angeles Calzado, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2021
Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysisMiriam A Schiele, Andreas Reif, Jiaxi Lin, et al.
Translational Psychiatry|February 6, 2019
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypesMichael G Gottschalk, Jan Richter, Christiane Ziegler, et al.
Molecular Psychiatry|August 10, 2022
Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traitsAet O'Leary, Noèlia Fernàndez-Castillo, Gabriela Gan, et al.
Annals of Hematology|January 25, 2023
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group studyDietger Niederwieser, Thomas Lang, Rainer Krahl, et al.
Translational Psychiatry|May 25, 2019
A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disordersChristopher Rayner, Jonathan R I Coleman, Kirstin L Purves, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 2, 2016
Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2Carrie M Nielson, Ching-Ti Liu, Albert V Smith, et al.
Pageof 23